Company Shenzhen Lifotronic Technology Co., Ltd.

Equities

688389

CNE100005WZ5

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Shenzhen Lifotronic Technology Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Diagnostic & Testing Substances

SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 21/05/2024 BST			5-day change	1st Jan Change
19.89 ^CNY	-1.63%		+0.20%	-11.64%

02-22	Shenzhen Lifotronic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Shenzhen Lifotronic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Shenzhen Lifotronic Technology Co Ltd is a China-based company mainly engaged in the research, development, manufacturing and marketing of medical devices. The Company focuses on the development and technological innovation of treatment and rehabilitation equipment, in vitro diagnostic equipment and supporting detection reagents. The Company's products mainly include wound and skin treatment products, perioperative and intensive care products, pain and rehabilitation treatment products and in vitro diagnostic products. The Company mainly conducts its businesses in domestic and overseas markets.

Number of employees: 1,481

CNY in Million	2022	Weight	2023	Weight	Delta
In Vitro Diagnostics - Test Reagent 45.3 %	480	48.9 %	518	45.3 %	+7.96%
In Vitro Diagnostics - Inspection Equipment 27.1 %	268	27.3 %	310	27.1 %	+15.68%
Treatment and Rehabilitation - Medical Products 25.1 %	218	22.1 %	288	25.1 %	+32.30%
Treatment and Rehabilitation - Household Products 1.4 %	10	1.0 %	16	1.4 %	+66.51%
Other Business 1.1 %	7	0.7 %	13	1.1 %	+78.40%

CNY in Million	2022	Weight	2023	Weight	Delta
China 71.4 %	653	66.9 %	809	71.4 %	+23.82%
Foreign 28.6 %	323	33.1 %	324	28.6 %	+0.47%

Managers	Title	Age	Since
Ming Long Hu CEO	Chief Executive Officer	55	31/12/13
Min Liu CHM	Chairman	55	31/12/07
Hong Wang DFI	Director of Finance/CFO	58	31/12/10
Lei Xiang		52	-
Jun Yang BRD	Director/Board Member	56	31/12/14
Ying Zeng BRD	Director/Board Member	55	31/12/12
Man Lu SEC	Corporate Secretary	34	31/12/20
Da Wei Li		-	-

Members of the board	Title	Age	Since
Ming Long Hu CEO	Chief Executive Officer	55	31/12/13
Xian Cheng Liu FOU	Founder	56	15/01/08
Ying Zeng BRD	Director/Board Member	55	31/12/12
Hong Wang DFI	Director of Finance/CFO	58	31/12/10
Jun Yang BRD	Director/Board Member	56	31/12/14
Lei Xiang BRD	Director/Board Member	52	31/12/07
Qiao Wu Cai BRD	Director/Board Member	60	01/11/20
Min Liu CHM	Chairman	55	31/12/07
Guang Hui Yang BRD	Director/Board Member	51	11-08
Hai Yan Zou BRD	Director/Board Member	59	11-08

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	428,114,047	195,727,283 ( 45.72 %)	0	45.72 %

Name	Equities	%	Valuation
Xian Cheng Liu 29.58 %	125,900,933	29.58 %	335 M ¥
Fullgoal Fund Management Co., Ltd. 9.532 %	40,567,136	9.532 %	108 M ¥
Xiamen Hanyu Investment Partnership LP 5.065 %	21,556,400	5.065 %	57 M ¥
Ming Long Hu 4.940 %	21,024,419	4.940 %	56 M ¥
Ying Zeng 4.622 %	19,669,021	4.622 %	52 M ¥
Shenzhen Capital Group Co., Ltd. 3.898 %	16,590,368	3.898 %	44 M ¥
Basic Pension Insurance Fund 16022 Portfolio 3.055 %	13,001,803	3.055 %	35 M ¥
Xiamen Qiaochuan Investment Partnership LP 2.995 %	12,744,575	2.995 %	34 M ¥
Yan Xu 2.947 %	12,542,040	2.947 %	33 M ¥
Basic Pension Insurance Fund 16021 Portfolio 1.762 %	7,500,443	1.762 %	20 M ¥

Shenzhen Lifotronic Technology Co., Ltd.

4/F, Building 15 1008 Xili Songbai Road

518000, Shenzhen

http://www.lifotronic.com

address Shenzhen Lifotronic Technology Co., Ltd.(688389)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

19.89 CNY

Average target price

23.86 CNY

Spread / Average Target

+19.98%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.	-11.64%	1.18B
BIOMÉRIEUX	-6.21%	12.09B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.26%	8.21B
DIASORIN S.P.A.	+5.36%	5.74B
LANTHEUS HOLDINGS, INC.	+31.20%	5.64B
AUTOBIO DIAGNOSTICS CO., LTD.	-9.05%	4.16B
10X GENOMICS, INC.	-56.99%	2.88B
ANDON HEALTH CO., LTD.	+11.87%	2.69B
VITROLIFE AB	-7.60%	2.33B
MYRIAD GENETICS, INC.	+25.34%	2.17B

Diagnostic & Testing Substances